Takeda, Ok., Hida, T., Sato, T., Ando, M., Seto, T., Satouchi, M. et al. Randomized part III trial of platinum-doublet chemotherapy adopted by gefitinib in contrast with continued platinum-doublet chemotherapy in Japanese sufferers with superior non-small-cell lung most cancers: outcomes of a west Japan thoracic oncology group trial (WJTOG0203). J Clin Oncol 28, 753–60 (2010).
Pao, W. & Chmielecki, J. Rational, biologically primarily based remedy of EGFR-mutant non-small-cell lung most cancers. Nat Rev Most cancers 10, 760–74 (2010).
Chen, W., Zheng, R., Zhang, S., Zhao, P., Zeng, H. & Zou, X. Report of most cancers incidence and mortality in China, 2010. Ann Transl Med 2, 61 (2014).
Siegel, R., Naishadham, D. & Jemal, A. Most cancers statistics, 2012. CA Most cancers J Clin 62, 10–29 (2012).
Byers, L. A. & Rudin, C. M. Small cell lung most cancers: The place can we go from right here? Most cancers (2014).
Xie, D., Lan, L., Huang, Ok., Chen, L., Xu, C., Wang, R. et al. Affiliation of p53/p21 expression and cigarette smoking with tumor development and poor prognosis in non-small cell lung most cancers sufferers. Oncol Rep 32, 2517–26 (2014).
Tessema, M., Yingling, C. M., Liu, Y., Tellez, C. S., Van Neste, L., Baylin, S. S. et al. Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from people who smoke and by no means people who smoke. Carcinogenesis 35, 1248–57 (2014).
Tessema, M., Yu, Y. Y., Stidley, C. A., Machida, E. O., Schuebel, Ok. E., Baylin, S. B. et al. Concomitant promoter methylation of a number of genes in lung adenocarcinomas from present, former and by no means people who smoke. Carcinogenesis 30, 1132–8 (2009).
Kwon, Y. J., Lee, S. J., Koh, J. S., Kim, S. H., Lee, H. W., Kang, M. C. et al. Genome-wide evaluation of DNA methylation and the gene expression change in lung most cancers. J Thorac Oncol 7, 20–33 (2012).
Yanagawa, N., Tamura, G., Oizumi, H., Endoh, M., Sadahiro, M. & Motoyama, T. Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking standing. Anticancer Res 31, 1211–4 (2011).
Nakata, S., Sugio, Ok., Uramoto, H., Oyama, T., Hanagiri, T., Morita, M. et al. The methylation standing and protein expression of CDH1, p16(INK4A) and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, medical options and prognostic significance. Most cancers 106, 2190–9 (2006).
Jiang, H., Solar, M. W., Hefright, B., Chen, W., Lu, C. D. & Zeng, J. Efficacy of hypocaloric parenteral vitamin for surgical sufferers: a scientific evaluate and meta-analysis. Clin Nutr 30, 730–7 (2011).
Coory, M. D. Touch upon: Heterogeneity in meta-analysis ought to be anticipated and appropriately quantified. Int J Epidemiol 39, 932 (2010).
Gates, P., Jaffe, A. & Copeland, J. Hashish smoking and respiratory well being: consideration of the literature. Respirology 19, 655–62 (2014).
Xie, A., Croce, B. & Tian, D. H. Smoking and lung most cancers. Ann Cardiothorac Surg 3, 221 (2014).
Tan, Q., Wang, G., Huang, J., Ding, Z., Luo, Q., Mok, T. et al. Epigenomic evaluation of lung adenocarcinoma reveals novel DNA methylation patterns related to smoking. Onco Targets Ther 6, 1471–9 (2013).
Suda, Ok., Tomizawa, Ok., Yatabe, Y. & Mitsudomi, T. Lung cancers unrelated to smoking: characterised by single oncogene dependancy? Int J Clin Oncol 16, 294–305 (2011).
Uimonen, Ok., Merikallio, H., Paakko, P., Harju, T., Mannermaa, A., Palvimo, J. et al. GASC1 expression in lung carcinoma is related to smoking and prognosis of squamous cell carcinoma. Histol Histopathol 29, 797–804 (2014).
Massion, P. P., Zou, Y., Chen, H., Jiang, A., Coulson, P., Amos, C. I. et al. Smoking-related genomic signatures in non-small cell lung most cancers. Am J Respir Crit Care Med 178, 1164–72 (2008).
Ling, Q., Shi, W., Huang, C., Zheng, J., Cheng, Q., Yu, Ok. et al. Epigenetic silencing of twin oxidase 1 by promoter hypermethylation in human hepatocellular carcinoma. Am J Most cancers Res 4, 508–17 (2014).
Lin, R. Ok., Hsieh, Y. S., Lin, P., Hsu, H. S., Chen, C. Y., Tang, Y. A. et al. The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung most cancers sufferers. J Clin Make investments 120, 521–32 (2010).
Kobayashi, T., Wang, J., Al-Ahmadie, H. & Abate-Shen, C. ARF regulates the soundness of p16 protein through REGgamma-dependent proteasome degradation. Mol Most cancers Res 11, 828–33 (2013).
Jarmalaite, S., Kannio, A., Anttila, S., Lazutka, J. R. & Husgafvel-Pursiainen, Ok. Aberrant p16 promoter methylation in people who smoke and former people who smoke with nonsmall cell lung most cancers. Int J Most cancers 106, 913–8 (2003).
Beckedorff, F. C., Ayupe, A. C., Crocci-Souza, R., Amaral, M. S., Nakaya, H. I., Soltys, D. T. et al. The intronic lengthy noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, lowering the expression of RASSF1A and growing cell proliferation. PLoS Genet 9, e1003705 (2013).
Ekim, M., Caner, V., Buyukpinarbasili, N., Tepeli, E., Elmas, L. & Bagci, G. Willpower of O(6)-methylguanine DNA methyltransferase promoter methylation in non-small cell lung most cancers. Genet Take a look at Mol Biomarkers 15, 357–60 (2011).
Phrase, B., Lyn-Cook dinner, L. E., Jr, Mwamba, B., Wang, H., Lyn-Cook dinner, B. & Hammons, G. Cigarette smoke condensate induces differential expression and promoter methylation profiles of essential genes concerned in lung most cancers in NL-20 lung cells in vitro: short-term and persistent publicity. Int J Toxicol 32, 23–31 (2013).
Evans, T. R. & Kaye, S. B. Retinoids: current position and future potential. Br J Most cancers 80, 1–8 (1999).
Moison, C., Senamaud-Beaufort, C., Fourriere, L., Champion, C., Ceccaldi, A., Lacomme, S. et al. DNA methylation related to polycomb repression in retinoic acid receptor beta silencing. FASEB J 27, 1468–78 (2013).
Ye, M., Li, D., Zhou, F., Guo, Q. & Xia, B. Epigenetic regulation of death-associated protein kinase expression in main gastric cancers from Chinese language sufferers. Eur J Most cancers Prev 21, 241–6 (2012).
Hu, S. L., Kong, X. Y., Cheng, Z. D., Solar, Y. B., Shen, G., Xu, W. P. et al. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma. Tumori 96, 726–33 (2010).
Kim, J. S., Kim, H., Shim, Y. M., Han, J., Park, J. & Kim, D. H. Aberrant methylation of the FHIT gene in persistent people who smoke with early stage squamous cell carcinoma of the lung. Carcinogenesis 25, 2165–71 (2004).
Liu, Y. L., Yang, H. P., Zhou, X. D., Gong, L., Tang, C. L. & Wang, H. J. The hypomethylation agent bisdemethoxycurcumin acts on the WIF-1 promoter, inhibits the canonical Wnt pathway and induces apoptosis in human non-small-cell lung most cancers. Curr Most cancers Drug Targets 11, 1098–110 (2011).
Zhang, B., Zhu, W., Yang, P., Liu, T., Jiang, M., He, Z. N. et al. Cigarette smoking and p16INK4alpha gene promoter hypermethylation in non-small cell lung carcinoma sufferers: a meta-analysis. PLoS One 6, e28882 (2011).
Liu, W. J., Tan, X. H., Guo, B. P., Ke, Q., Solar, J. & Cen, H. Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of revealed knowledge. Asian Pac J Most cancers Prev 14, 3719–24 (2013).
Murphy, S. E., Park, S. S., Thompson, E. F., Wilkens, L. R., Patel, Y., Stram, D. O. et al. Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in 5 ethnic/racial teams. Carcinogenesis 35, 2526–2533 (2014).
Siegel, R., Ma, J., Zou, Z. & Jemal, A. Most cancers statistics, 2014. CA Most cancers J Clin 64, 9–29 (2014).
Tantraworasin, A., Lertprasertsuke, N., Kongkarnka, S., Euathrongchit, J., Wannasopha, Y. & Saeteng, S. Retrospective research of ALK rearrangement and clinicopathological implications in utterly resected non- small cell lung most cancers sufferers in Northern Thailand: position of screening with D5F3 antibodies. Asian Pac J Most cancers Prev 15, 3057–63 (2014).
